Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinical-level guide to recognizing, preventing, and managing adverse events from sulfonylurea therapy, including hypoglycemia protocols, weight gain strategies, and special-population dosing. Written for prescribers and pharmacists.
Read clinical reviewA prescriber- and pharmacist-level guide to sulfonylurea drug class pharmacology, formulary positioning, billing codes, and prior-authorization strategy for T2D management.
Read clinical reviewA comprehensive MD/PharmD-level monograph covering sulfonylurea pharmacology, clinical trial evidence, dosing, safety, drug interactions, and place in T2D therapy, reviewed by the HealthRX medical team.
Read clinical reviewA clinical-level DDI table for all major sulfonylureas, covering pharmacokinetic and pharmacodynamic interactions, severity ratings, and management guidance for prescribers and pharmacists.
Read clinical reviewA board-reviewed, MD/PharmD-level guide to the sulfonylureas monitoring bundle covering baseline labs, hypoglycemia protocols, renal and hepatic dose adjustments, cardiovascular safety, and drug interactions for glipizide, glyburide, and glimepiride.
Read clinical reviewA clinical-level review of sulfonylurea pharmacology, dosing, and special-population considerations for prescribers and pharmacists managing T2D.
Read clinical reviewEvidence-based titration schedules and tapering protocols for sulfonylureas (glipizide, glimepiride, glyburide) in type 2 diabetes, written for prescribers and dispensing pharmacists.
Read clinical reviewEvidence-based guide for clinicians on choosing between glipizide, glimepiride, and glyburide. Covers hypoglycemia risk, renal dosing, cardiovascular data, and patient-specific selection.
Read clinical review